Concert Pharmaceuticals, Inc. EBITDA Margin 2014-2022 | CNCE
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Concert Pharmaceuticals, Inc. (CNCE) over the last 10 years. The current EBITDA margin for Concert Pharmaceuticals, Inc. as of September 30, 2022 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2022-09-30 | $0.00B | $-0.12B | inf% |
| 2022-06-30 | $0.00B | $-0.12B | -12000.00% |
| 2021-12-31 | $0.03B | $-0.08B | -230.30% |
| 2021-09-30 | $0.03B | $-0.06B | -193.94% |
| 2021-06-30 | $0.03B | $-0.06B | -167.65% |
| 2021-03-31 | $0.01B | $-0.08B | -962.50% |
| 2020-12-31 | $0.01B | $-0.07B | -887.50% |
| 2020-09-30 | $0.01B | $-0.07B | -887.50% |
| 2020-06-30 | $0.01B | $-0.07B | -1166.67% |
| 2020-03-31 | $0.00B | $-0.08B | inf% |
| 2019-12-31 | $0.00B | $-0.08B | -7800.00% |
| 2019-09-30 | $0.00B | $-0.08B | -7700.00% |
| 2019-06-30 | $0.00B | $-0.08B | -7600.00% |
| 2019-03-31 | $0.00B | $-0.07B | -7100.00% |
| 2018-12-31 | $0.01B | $-0.06B | -550.00% |
| 2018-09-30 | $0.01B | $-0.05B | -480.00% |
| 2018-06-30 | $0.15B | $0.10B | 65.58% |
| 2018-03-31 | $0.15B | $0.10B | 66.23% |
| 2017-12-31 | $0.14B | $0.09B | 64.58% |
| 2017-09-30 | $0.14B | $0.09B | 65.28% |
| 2017-06-30 | $0.00B | $-0.05B | inf% |
| 2017-03-31 | $0.00B | $-0.05B | inf% |
| 2016-12-31 | $0.00B | $-0.05B | inf% |
| 2016-09-30 | $0.01B | $-0.04B | -370.00% |
| 2016-06-30 | $0.01B | $-0.03B | -283.33% |
| 2016-03-31 | $0.07B | $0.02B | 32.31% |
| 2015-12-31 | $0.07B | $0.03B | 39.39% |
| 2015-09-30 | $0.06B | $0.02B | 29.82% |
| 2015-06-30 | $0.06B | $0.02B | 30.51% |
| 2015-03-31 | $0.01B | $-0.03B | -442.86% |
| 2014-12-31 | $0.01B | $-0.03B | -350.00% |
| 2014-09-30 | $0.01B | $-0.03B | -312.50% |
| 2014-06-30 | $0.01B | $-0.03B | -500.00% |
| 2014-03-31 | $0.02B | $-0.01B | -38.10% |
| 2013-12-31 | $0.03B | $-0.00B | -12.00% |
